Uber Health to leverage blockchain

Amy Baxter | | Health Exec | Precision Medicine
Blockchain generic

Uber Health, the healthcare subsidiary of rideshare company Uber, has granted access of its American fleet to a blockchain startup, Forbes reported. The relationship establishes blockchain and cryptocurrency in the healthcare space.

The startup, Solve.Care, uses Ethereum blockchain to connect the healthcare ecosystem through blockchain, which is a digital ledger of transactions that was popularized by the rise of cryptocurrencies. Solve.Care clients will be able to schedule doctor’s visits, book rides to healthcare appointments and pay for the services through cryptocurrency tokens by the company––a first for Uber payments.

Patients can pay for the services through the solve token or the care coin through the Ethereum blockchain, though Uber drivers won’t be paid directly in cryptocurrency.

See the full story below:

Uber Subsidiary Grants Ethereum Startup Access To Entire American Fleet

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”